Life sciences company Parse Biosciences has partnered with research institute Graph Therapeutics to create what it says is one of the largest and most comprehensive immune cell perturbation atlases.  The collaboration will leverage Graph's lab-in-the-loop platform with Parse's GigLab to profile hundreds of millions of cells from patients with immune diseases under systematic perturbation, making the immune system’s highly dynamic behaviour […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!